The testing, which is part of the APPROACH study, will allow some pharmacies in Nova Scotia, Newfoundland and Labrador, and Alberta to test for HIV, hepatitis C and syphilis.
The Alberta College of Pharmacy is asking pharmacists who are compounding infants’ and children’s acetaminophen to match commercial concentrations and packaging sizes to help prevent overdoses in children.